The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis

Liver Int. 2018 Apr;38(4):570-580. doi: 10.1111/liv.13589. Epub 2018 Jan 15.

Abstract

Patients with cirrhosis and portal hypertension often develop complications from a variety of organ systems leading to a multiple organ failure. The combination of liver failure and portal hypertension results in a hyperdynamic circulatory state partly owing to simultaneous splanchnic and peripheral arterial vasodilatation. Increases in circulatory vasodilators are believed to be due to portosystemic shunting and bacterial translocation leading to redistribution of the blood volume with central hypovolemia. Portal hypertension per se and increased splanchnic blood flow are mainly responsible for the development and perpetuation of the hyperdynamic circulation and the associated changes in cardiovascular function with development of cirrhotic cardiomyopathy, autonomic dysfunction and renal dysfunction as part of a cardiorenal syndrome. Several of the cardiovascular changes are reversible after liver transplantation and point to the pathophysiological significance of portal hypertension. In this paper, we aimed to review current knowledge on the pathophysiology of arterial vasodilatation and the hyperdynamic circulation in cirrhosis.

Keywords: cardiac dysfunction; liver failure; multi-organ syndrome; portal hypertension.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adrenal Insufficiency
  • Arterial Pressure
  • Cardiac Output
  • Collateral Circulation
  • Humans
  • Hypertension, Portal / drug therapy
  • Hypertension, Portal / etiology*
  • Hypertension, Portal / physiopathology
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / physiopathology*
  • Liver Failure / etiology*
  • Liver Failure / physiopathology
  • Multiple Organ Failure
  • Splanchnic Circulation / drug effects*
  • Vascular Resistance
  • Vasoconstrictor Agents / therapeutic use
  • Vasodilation / drug effects*

Substances

  • Vasoconstrictor Agents